|Bid||113.65 x 1000|
|Ask||113.00 x 800|
|Day's Range||113.08 - 115.64|
|52 Week Range||92.14 - 143.87|
|Beta (5Y Monthly)||0.98|
|PE Ratio (TTM)||30.45|
|Earnings Date||Nov 02, 2020 - Nov 06, 2020|
|Forward Dividend & Yield||3.08 (2.71%)|
|Ex-Dividend Date||Sep 23, 2020|
|1y Target Est||137.40|
Moody's Investors Service, ("Moody's") assigned a Baa3 rating to Nutrition & Biosciences, Inc.'s ("N&B") new senior unsecured notes. The Baa3 ratings of International Flavors & Fragrances, Inc. ("IFF") and its Prime-3 rating for commercial paper remain unchanged.
Moody's Investors Service, ("Moody's") affirmed the Baa3 ratings of International Flavors and Fragrances, Inc. ("IFF") and its Prime-3 rating for commercial paper. "The affirmation reflects the benefits of the merger with DuPont's Nutrition and Biosciences including increased scale and product offering offset by the increased leverage and credit metrics that are elevated for an investment-grade rating and challenges related to integrating the two companies," said Domenick R. Fumai, Moody's Vice President and lead analyst for IFF.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Innophos Holdings, Inc. (New) and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion.